Survey the effect of magnesium citrate supplementation on clinical symptoms and TNF-a and hs-CRP factors in patients with COVID-19
Phase 3
Recruiting
- Conditions
- covid-19.COVID-19, virus identified.U07.1
- Registration Number
- IRCT20210413050957N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Laboratory confirmation of Covid-19 (2019-nCoV Real-Time RT-PCR)
Patients with moderate status
Age from 18 to 65 years
gender: male/female
Exclusion Criteria
Hospitalization of the patient in the intensive care unit
Underlying diseases such as diabetes, hypertension, cardiovascular disease, kidney disease and mental disorders such as depression
Obesity (BMI = 30)
Vitamin D level less than 30 ng / ml
Hypomagnesemia (magnesium level less than 1.7 mg / dL) and hypermagnesemia (magnesium level higher than 2.6 mg / dL)
Pregnancy and lactation
Contraindications, intolerance or allergy to magnesium
Taking dietary supplements
Alcohol and drug abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method